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Abstract 
Background 
Acute and chronic pain in axial structures, like the back and neck, are difficult to treat, and 
have incidence as high as 15%. Surprisingly, most preclinical work on pain mechanisms 
focuses on cutaneous structures in the limbs and animal models of axial pain are not widely 
available. Accordingly, we developed a mouse model of acute cervical muscle inflammation 
and assessed the functional properties of superficial dorsal horn (SDH) neurons. 
Results 
Male C57/Bl6 mice (P24-P40) were deeply anaesthetised (urethane 2.2 g/kg i.p) and the 
rectus capitis major muscle (RCM) injected with 40 µl of 2% carrageenan. Sham animals 
received vehicle injection and controls remained anaesthetised for 2 hrs. Mice in each group 
were sacrificed at 2 hrs for analysis. c-Fos staining was used to determine the location of 
activated neurons. c-Fos labelling in carrageenan-injected mice was concentrated within 
ipsilateral (87% and 63% of labelled neurons in C1 and C2 segments, respectively) and 
contralateral laminae I - II with some expression in lateral lamina V. c-Fos expression 
remained below detectable levels in control and sham animals. In additional, experiments 
whole cell recordings were obtained from visualised SDH neurons in transverse slices in the 
ipsilateral C1 and C2 spinal segments. Resting membrane potential and input resistance were 
not altered. Mean spontaneous EPSC amplitude was reduced by ~20% in neurons from 
carrageenan-injected mice versus control and sham animals (20.63 ± 1.05 vs 24.64 ± 0.91 and 
25.87 ± 1.32 pA, respectively). The amplitude (238 ± 33 vs 494 ± 96 and 593 ± 167 pA) and 
inactivation time constant (12.9 ± 1.5 vs 22.1 ± 3.6 and 15.3 ± 1.4 ms) of the rapid A type 
potassium current (IAr), the dominant subthreshold current in SDH neurons, were reduced in 
carrageenan-injected mice. 
Conclusions 
Excitatory synaptic drive onto, and important intrinsic properties (ie, IAr) within SDH neurons 
are reduced two hours after acute muscle inflammation. We propose this time point 
represents an important transition period between peripheral and central sensitisation with 
reduced excitatory drive providing an initial neuroprotective mechanism during the early 
stages of the progression towards central sensitisation. 
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Introduction 
Acute inflammation in peripheral structures, such as muscle, results in nociceptor activation 
and pain. Unfortunately, pain sometimes outlasts the initial inflammatory insult and persists 
in a more chronic form. Long-term changes in components of the pain neuroaxis such as 
altered synapses and neuronal properties are thought to underlie this process [1]. 
Understanding the mechanisms involved in the progression from the acute to chronic pain 
state, however, remains a major challenge in pain neurobiology. 
Regardless of the site involved in chronic pain states, the central processing of nociceptive 
signals begins in the superficial dorsal horn (SDH; laminae I-II) of the spinal cord [2]. Here, 
the passage of information to be relayed from primary afferent fibres to higher brain regions 
can be gated by synaptic inputs from local segmental interneurons and descending brainstem 
centres. Such a process greatly influences whether nociceptor activation can ultimately be 
perceived as pain [3]. Since the initial discovery that the electrophysiological properties of 
neurons in the lumbar spinal cord could be altered after repeated noxious peripheral input [4], 
plasticity in spinal cord pain circuits, termed central sensitisation, has been considered a key 
element in the development of chronic pain [5,6]. 
Surprisingly, most of our understanding of the spinal mechanisms underlying plasticity in 
pain circuits comes from studies on the rodent hindlimb following nerve injury or 
inflammation, even though there is both clinical and pre-clinical evidence suggesting that 
such mechanisms may differ for axial and limb pain [7]. Patients with neck pain often 
complain of a range of symptoms not obviously associated with damage to neck structures. 
These include dizziness, visual disturbances, general weakness, numbness or parathesis, 
cutaneous hyperalgesia, as well as psychological symptoms such as disturbances in 
concentration and memory [8]. These signs and symptoms are not normally associated with 
limb pain where sensory disturbances tend to be more localised [9]. At the cellular level we 
know that upper cervical SDH neurons receive input from a unique combination of tissues 
including cutaneous and deep structures in the neck, head and cranial vault [10,11]. This 
afferent convergence presumably plays an important role in the complex presentation of pain 
originating in neck tissues [12]. Together these data suggest the mechanisms underlying 
processing of nociceptive signals originating in neck structures differ from those in the limbs, 
and may be important for the development of neck pain and its symptoms. 
In order to begin to understand the spinal mechanisms that underlie the development of 
chronic neck pain, we assessed the impact of acute muscle inflammation on the synaptic and 
intrinsic properties of SDH neurons in the mouse upper cervical spinal cord. After two hours 
of acute inflammation of the rectus capitus major (RCM) muscle we find excitatory synaptic 
drive to SDH neurons and the rapid A-type potassium current are reduced in SDH neurons. 
We hypothesise that two hours post inflammation is an important epoch during the cascade of 
events where aberrant nociceptive signaling transitions from a peripheral to central locus. 
Methods 
The University of Newcastle Animal Care & Ethics Committee approved all experimental 
procedures. Male C57/Bl6 mice (P24 - P40) were deeply anaesthetised with urethane (2.2 
g/kg i.p) and underwent the following treatments: control animals remained anaesthetised for 
2 hrs; sham animals received a unilateral injection of 40 µl phosphate-buffered saline (PBS, 
pH 7.4) via a 26 gauge needle into the RCM muscle; experimental animals received an 
injection of 2% carrageenan (in phosphate buffered saline - PBS) into the RCM. This muscle 
is particularly large in rodents and runs from the spinous process of C2 to the skull. It is 
easily located by palpating the external occipital protuberance (inion) and the spinous process 
of the C7 vertebrae. The location of the C1 spinous process in the mouse is one-fifth the 
distance between the inion and the C7 spinous process. The needle was inserted just lateral to 
the midline at the level of C1 (angled ~45o to the horizontal). The needle was inserted until it 
reached the occiput and withdrawn so the tip remained in the RCM muscle belly. Mice were 
maintained under anaesthetic for two hours prior to preparation for immunohistochemistry or 
electrophysiology. 
Immunohistochemistry 
After two hours of urethane anaesthesia animals were further injected with Ketamine (100 
mg/kg), and perfused through the ascending aorta with PBS (20 ml), followed by 20 ml of 
4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4). The cervical spinal cord (obex 
- C5) was removed and post-fixed in 4% paraformaldehyde (two hours) prior to washing with 
PB and cryoprotection in PB containing 30% sucrose at 4°C for 48 hrs. Serial transverse 
sections (60 µm) were cut and every 5th section was processed for Fos-like 
immunoreactivity. 
Sections from control carrageenan-injected (n = 3), sham (PBS; n = 3), and (uninjected; n = 
4) animals were incubated in 50% ethanol for 30 minutes to enhance antibody penetration 
and then incubated in 0.03% hydrogen peroxide in PB for 20 minutes to block endogenous 
peroxide activity. Sections were then incubated for 72 hours with a polyclonal goat anti-fos 
antibody (diluted 1:1000 in PBS; Santa Cruz Biotechnology, Santa Cruz, CA, USA), 
followed by a biotinylated donkey anti-goat IgG secondary antibody (1:500; Jackson 
Immunoresearch, West Grove, PA, USA) for an additional 24 hours. Sections were then 
incubated in ExtrAvidin-peroxidase (diluted 1:1000. Sigma-Aldrich; Cat no. E2886) and 
peroxidase labeling visualised using 3′3′-diamino-benzadine (DAB) as a chromagen. All 
antibodies and the peroxidase-labelled ExtrAvidin were diluted in PBS containing 0.3% 
Triton X-100. Sections were then dehydrated, cleared and mounted in serial order on slides. 
The relative position of all c-Fos positive cells within the C1 and C2 segments were plotted 
onto templates of the appropriate spinal segment (adapted from [13]) using Adobe Illustrator 
CS4 (Adobe Systems Inc., San Jose, CA, U.S.A). Mean number of c-Fos positive cells per 
spinal segment was calculated from these data. 
Electrophysiology 
Sham (n = 15 mice) and carrageenan injected mice (n = 10) were decapitated as close as 
possible to the thorax while still under urethane anaesthesia. Control animals (uninjected; n = 
16 mice) were anaesthetised with ketamine (100 mg/kg i.p) before decapitation. The cervical 
vertebral column was isolated and immersed in ice-cold oxygenated sucrose substituted 
artificial cerebrospinal fluid (s-ACSF) containing (in mM): 250 sucrose, 25 NaHCO3, 10 
glucose, 2.5 KCl, 1 NaH2PO4, 1 MgCl2, 2.5 CaCl2. The spinal cord was removed and a 
shallow cut made down the contralateral side of the spinal cord (ventral surface) to identify 
the ipsilateral side for recording. Transverse slices (300 µm thick) were obtained from the 
C1-C2 region using a vibratome (Leica VT-1000S; Leica Microsystems, Wetzlar, Germany). 
All slices were transferred to an interface storage chamber containing oxygenated ACSF (118 
mM NaCl substituted for sucrose in s-ACSF), and allowed to equilibrate for 1 hr at room 
temperature (approximately 22-24°C), prior to recording. 
Slices were placed in a recording bath and continually superfused (4–6 bath volumes/min) 
with ACSF maintained at near-physiological temperature (33°C). Whole cell patch clamp 
recordings were obtained from visualised SDH neurons (lamina I-II) using infrared 
differential interference contrast optics and an infrared-sensitive camera (Hamamatsu C2400-
79C, Hamamatsu City, Japan). Recordings were restricted to the SDH by targeting neurons 
within or dorsal to the substantia gelatinosa (lamina II), which appears as a translucent band 
in transverse spinal cord slices. Patch pipettes (2–5 MΩ) were filled with a K+-based internal 
solution containing (in mM): 135 KCH3SO4, 6 NaCl, 2 MgCl2, 10 HEPES, 0.1 EGTA, 2 
MgATP, 0.3 NaGTP, adjusted to a pH of 7.3 with KOH. Whole cell recordings were obtained 
using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA), connected to 
a Macintosh G4 computer via an InstruTECH ITC18 digitiser (HEKA Instruments, Bellmore, 
NY, USA). 
The whole cell recording configuration was first established in voltage clamp (holding 
potential −60 mV). Series resistance (Rs), input resistance (RIN), and capacitance were 
measured from the averaged response (5 repetitions) to a 5 mV hyperpolarising voltage step. 
These parameters were observed following each protocol, and data were rejected if values 
changed by >20%. Initially, spontaneous excitatory post-synaptic currents (sEPSCs) were 
recorded for each neuron in voltage-clamp (holding potential −60 mV; 60 s duration). The 
recording mode was then switched to current clamp. The membrane potential recorded 
following this switch (~15 s later) was designated resting membrane potential (RMP). A 
series of depolarising ‘step-current’ injections (20 pA increments; 800 ms, delivered every 8 
s) were then injected in order to study action potential (AP) discharge in each recorded 
neuron. Finally, the recording configuration was returned to voltage clamp and a protocol 
was run to study voltage-gated subthreshold ionic currents. This protocol first hyperpolarised 
the membrane potential to −90 mV (for 1 s) before delivering a depolarising step to −40 mV 
(for 200 ms) before returning to −60 mV. All membrane currents were filtered at 2 kHz and 
stored on a Macintosh G4 computer using Axograph v.10 (Axon Instruments, Foster City, 
CA, USA) for future analysis. 
Data analysis 
All data were analysed off-line using semi-automated procedures within Axograph software. 
sEPSCs were detected and captured using a scaled template method and subsequently 
inspected [14]. Some events were rejected if they overlapped or did not include a stable 
baseline before the rising phase of the captured event. For each recording, stationarity plots of 
sEPSC interevent interval were constructed for the duration of the analysis period. These 
plots were inspected to ensure no time dependent change or heavy clustering of data points, 
which would both be indicative of burst activity, were included in the analysis. Several 
sEPSC parameters were measured including mean amplitude, rise time, decay time and 
instantaneous frequency. Individual APs evoked during step current injection were detected 
and captured using the derivative threshold method for spike initiation (set at dV/dt ≥ 20 
Vs−1). The pattern of AP discharge was classified into categories using previously described 
criteria [15,16] as; single spiking, initial bursting, tonic firing, delayed firing, or reluctant 
firing. Likewise, subthreshold currents (IAr, IAs, T-type calcium, Ih, & mixed) were classified 
and compared between control, sham and experimental (carrageenan-injected) animals. 
Statistical analysis 
All statistical analyses were carried out using SPSS statistics software v.18.0 (SPSS Inc., 
Chicago, IL, USA). One-way ANOVA coupled with Student-Newman-Keuls and Scheffe 
post-hoc tests were used to compare variables from control, sham and experimental animals. 
Data with unequal variances were compared using the non-parametric Kruskal-Wallis test. 
Chi-square tests were utilised to determine whether the prevalence of discharge categories 
and subthreshold currents differed between the groups. Statistical significance was set at p < 
0.05. All values are presented as the mean ± S.E.M. 
Results 
Experiments were designed to characterise the early events that occur in SDH neurons 
following acute neck muscle inflammation. To establish the segmental level and distribution 
of activated neurons, spinal cords were processed to visualise the immediate early gene 
product c-Fos (Figure 1). The level of neuronal activation (determined by number of c-Fos 
positive profiles) was assessed in the C1-C2 spinal segments of control, sham, and 
carrageenan-injected animals. 
Figure 1 Neck muscle inflammation activates upper-cervical dorsal horn neurons. A. 
Representative image of a transverse spinal cord section (C2 level) from a carrageenan-
injected animal showing cFos labelling in the ipsilateral dorsal horn. Note, labeled neurons 
are concentrated in the superficial dorsal horn with a lateral bias. B. Maps showing group 
data from carrageenan-injected animals. The location of cFos labeled neurons have been 
collapsed onto standardised C1 and C2 templates (adapted from [13]). C. Graph comparing 
mean number of cFos positive neurons in control, sham, and carrageenan-injected animals. 
Data are separated into ipsilateral and contralateral staining across spinal levels C1 and C2. 
c-Fos expression remained below detectable levels in the C1-C2 spinal segments of control 
(un-injected; n = 4) and sham (PBS-injected; n = 3) mice. In contrast, spinal cord sections 
from carrageenan-injected animals contained substantial c-Fos expression in both ipsilateral 
and contralateral dorsal horns (Figure 1). This expression was concentrated in the SDH 
region (laminae I - II) in C1 and C2 spinal segments, with some scattered expression in 
lateral lamina V. The number of c-Fos positive neurons was much higher in the ipsilateral 
versus contralateral dorsal horn (C1, 40 ± 9 vs 6 ± 4 cells/section; C2, 23 ± 4 vs 14 ± 4 
cells/section). Our analysis also showed that carrageenan injection into the RCM muscle 
resulted in greater neuronal activation in the C1 versus C2 spinal segment and the ipsilateral 
versus contralateral bias was more pronounced in C1 segments (i.e. C1 - ipsi 87% versus 
contra 13% of c-Fos positive cells; C2 - ipsi 62% vs contra 38% of c-Fos positive cells). In 
summary, the greatest degree of neuronal activation following acute inflammation of the 
RCM muscle occurred in the ipsilateral SDH of the C1 spinal segment. Electrophysiological 
recordings were therefore obtained on the ipsilateral side of slices prepared from C1 and C2 
spinal cord segments from control, sham, or carrageenan-injected animals. 
Whole cell patch-clamp recordings were obtained from 205 SDH neurons in 41 animals from 
carrageenan-injected (n = 58 cells from 10 mice), sham (n = 68 cells from 15 mice), and 
control (n = 79 cells from 16 mice) animals. These experiments examined a range of 
electrophysiological properties known to contribute to neuronal excitability and plasticity. 
The location of recorded neurons was documented in latter experiments (after image capture 
software) to ensure similar sampling occurred throughout the SDH under all experimental 
conditions. Figure 2 summarises the results of this analysis and confirms that similar regions 
of the upper cervical SDH were sampled in carrageenan-injected, sham and control mice (n = 
33, 39, and 36 neurons, respectively). 
Figure 2 Location of recorded neurons in spinal cord slices. The location of recorded 
neurons was documented to check and account for bias. Low magnification images (5×) were 
captured at the conclusion of recording sessions with the recording pipette still in place. 
Recording locations were then plotted on a standardised transverse template of the upper 
cervical spinal cord. Recording locations were then consolidated onto a single template for 
control, sham, and carrageenan-injected experiments. Comparison of these maps indicates 
similar sampling in both mediolateral and dorsoventral planes for each experimental 
condition. 
Several passive membrane properties did not differ in neurons from carrageenan-injected, 
sham and control mice. These included input resistance (447.9 ± 33.1 MΩ vs. 395.1 ± 28.6 
MΩ vs. 401.9 ± 23.8 MΩ, carrageenan-injected, sham and control, n = 58, 68, & 79 
respectively, p = 0.42) and RMP (−59.2 ± 1.5 mV vs. -58.0 ± 1.4 mV vs. -60.7 ± 1.3 mV; p = 
0.39). These results suggest acute neck muscle inflammation does not alter the passive 
properties of upper cervical SDH neurons. 
We next recorded spontaneous excitatory postsynaptic currents (sEPSCs) to determine 
whether acute neck muscle inflammation alters excitatory synaptic drive in spinal circuits 
(Figure 3). sEPSCs represent the postsynaptic response to action potential dependent and 
spontaneous neurotransmitter release from presynaptic terminals. Mean sEPSC frequency 
was similar in carrageenan-injected, sham and control animals (2.13 ± 0.31 Hz vs. 2.69 ± 
0.40 Hz vs. 2.92 ± 0.37 Hz, n = 58, 68, & 79 respectively; p = 0.31) (Figure 3B). sEPSCs 
time course was also similar with mean values for rise time (0.65 ± 0.02 ms vs. 0.65 ± 0.02 
ms vs. 0.68 ± 0.02 ms, respectively; p = 0.39) and decay time constant (2.14 ± 0.08 ms vs. 
2.23 ± 0.11 ms vs. 2.33 ± 0.10 ms, respectively; p = 0.39) being similar in carrageenan-
injected, sham and control animals. In contrast, mean sEPSC amplitude was reduced by 
~20% in neurons from carrageenan-injected mice (20.63 ± 1.05 vs 24.64 ± 0.91 and 25.87 ± 
1.32 pA, carrageenan-injected, sham and control, respectively; p = 0.004) (Figure 3C). The 
combined effect of these properties would result in a ~30% charge transfer (calculated as area 
under curve) in carrageenan-injected animals (66.55 ± 4.02 pA.ms vs. 91.50 ± 6.06 pA.ms vs. 
96.94 ± 4.17 pA.ms; carrageenan-injected, sham, and control animals, respectively; p = 
0.0001). Thus, excitatory drive to SDH neurons is reduced significantly in the ipsilateral 
dorsal horn following acute neck muscle inflammation. 
Figure 3 Excitatory synaptic drive is altered in the upper cervical dorsal horn by acute 
neck muscle inflammation. A. Raw data showing representative spontaneous excitatory 
postsynaptic currents (sEPSCs, 30 s of continuous data) in SDH neurons from control, sham, 
and carrageenan-injected animals. sEPSCs were blocked by CNQX (10 µM, not shown). B. 
Stationarity plots of sEPSC interevent interval (IEI) for the control, sham, and carrageenan-
injected recordings shown in A. Note that these plots do not contain any time dependent 
trends, or tight clustering of data points that would indicate sEPSC bursting. C. Group data 
showing mean (left) and instantaneous (right) sEPCS frequency were similar in control, 
sham, and carrageenan-injected animals. D. Group data shows sEPCS amplitude (left) was 
significantly reduced in carrageenan-injected animals. Overlaid average sEPSC amplitude 
histograms (right) show a leftward shift in the distribution for carrageenan-injected animals. 
In a subset of recordings (n = 48, 44, 58; control, sham and carrageenan-injected, 
respectively) we examined AP discharge, evoked by step current injection, to assess whether 
acute neck muscle inflammation altered the intrinsic properties (and excitability) of upper 
cervical SDH neurons. The features of voltage responses exhibited at multiple current step 
injections were used to classify AP discharge patterns into five categories, as previously 
described [15,16]. Single spiking neurons, discharged one AP at the beginning of step current 
injection regardless of current intensity; initial bursting neurons discharged a brief, adapting 
train of APs limited to the beginning of the current step; tonic firing neurons exhibited 
sustained discharge for the duration of the current step; delayed firing neurons discharged 
APs after a delay from step current onset; and reluctant firing neurons failed to fire APs in 
response to any current step, independent of intensity. All discharge patterns were observed 
under the three experimental conditions (Figure 4A), and there was no significant difference 
in the proportion of these discharge categories in control, sham and carrageenan-injected 
animals (Figure 4B, χ2; p = 0.27). 
Figure 4 Acute neck muscle inflammation does not alter action potential discharge 
properties. A. Dorsal horn neurons can be classified by the temporal features of their action 
potential discharge. We have previously described five AP discharge patterns under in vitro 
[16] and in vivo conditions [15], and also across the lumbar, thoracic and cervical spinal cord 
in adult mice [17]. Traces show representative examples of each AP discharge pattern (Tonic 
Firing - TF, Initial Bursting - IB, Delayed Firing - DF, Single Spiking - SS, and Reluctant 
Firing RF) recorded from control (left), sham (middle), and carrageenan-injected animals 
(right). Horizontal bars denote −50 mV membrane potential. B. The incidence of the five AP 
discharge patterns was similar in control, sham, and carrageenan-injected animals. 
In some neurons we also tested for the presence of the four main subthreshold currents that 
shape AP discharge in SDH neurons (n = 38, 39, 41; carrageenan-injected, sham, and control, 
respectively, Figure 5). This analysis employed a voltage-step protocol to identify different 
subthreshold currents in adult mouse SDH neurons [18]. These include two types of outward 
potassium current that are activated by a depolarising step (−90 to −40 mV). The first 
displays fast activation and inactivation kinetics and is termed a rapid A-type current (IAr), 
while a second exhibits slower activation/inactivation kinetics and is termed a slow A-type 
current (IAs). These two currents are easily differentiated as the rapid form (IAr) was fully 
inactivated during a 200 ms activation step (to −90 to -40 mV), whereas the slower form did 
not fully inactivate over the same period. A criterion threshold of 50 ms for the outward 
current inactivation time constant was used to classify currents as either IAr (<50 ms) or IAs 
(>50 ms). This approach resulted in two non-overlapping distributions in recordings from 
control, sham and carrageenan-injected mice. The other major subthreshold current types are 
inward currents. The first is an inward current with rapid activation/inactivation kinetics (in 
response to a −90 mV to −40 mV step), consistent with the low threshold ‘T-type calcium 
current’ (ICa; Figure 5A). The second, inward current is activated by hyperpolarisation (−60 
mV to −90 mV step) and exhibits slow activation kinetics consistent with the well-described 
current termed Ih (Figure 5A). Importantly, coexpression of the currents observed using our 
protocol was not frequently observed. For example, a combination of ICa and Ih occurred in 
<10% of the neurons sampled (n = 4/41, 2/39, and 2/38, control, sham and carrageenan-
injected respectively). Co-expression of other currents was not directly assessed in these 
experiments, as this would have required pharmacological analysis, and limited the collection 
of data that was the principal focus of our experiments. Previous work using pharmacological 
analysis, albeit in lumbar SDH neurons, suggests a single subthreshold current typically 
dominates in response to our protocol [18]. We do not discount the possibility, however, that 
combinations of IAr, IAs, and ICa may exist in some of these neurons or that the incidence of 
mixed currents is higher in upper cervical SDH neurons. 
Figure 5 Acute neck muscle inflammation alters subthreshold voltage-activated 
currents. A. Traces show representative voltage-activated current recordings (from control, 
sham, and carrageenan-injected animals) in response to voltage step protocol (bottom black 
traces, note different scale for lower right Ih currents). We have previously shown this 
protocol identifies one of four dominant currents in dorsal horn neurons: rapid A-type 
potassium currents (IA rapid); slow A-type potassium currents (IA slow); T-type calcium currents 
(ICa); and a hyperpolarisation-activated non-selective cation current (Ih). Analysis of these 
currents across the three experimental conditions showed the characteristics of IA slow, ICa, or 
Ih did not differ under the three conditions. In contrast, the amplitude of the IA rapid current was 
reduced in carrageenan-injected animals (see text). B. Plots show the incidence of sub-
threshold voltage activated current types was similar in control, sham, and carrageenan-
injected animals. 
Each of the four subthreshold currents was present in neurons from control, sham, and 
carrageenan-injected animals (Figure 5B). Under each condition, IAr and IAs were the 
dominant currents, while ICa and Ih was observed in < 30% of neurons. Collectively, the 
relative proportion of each subthreshold current did not differ across groups (Figure 5B, χ2; p 
= 0.27). Further analysis showed the properties of IAs, ICa and Ih were similar under control, 
sham and carrageenan-injection conditions. Specifically, the mean amplitude of IAs (606 ± 
309 pA vs. 617 ± 107 pA vs. 475 ± 113 pA, for carrageenan-injected, sham and control; n = 
4, 6, & 5 respectively, p = 0.81) and mean inactivation time constant (130.1 ± 15.5 ms vs. 
140.9 ± 14.1 ms vs. 181.0 ± 38.2 ms, respectively; p = 0.30) were similar across experimental 
conditions. Mean amplitude of ICa (153 ± 43 pA vs. 273 ± 137 pA vs. 194 ± 80 pA, for 
carrageenan-injected, sham and control; n = 7, 5, & 8 respectively, p = 0.61) and mean 
inactivation time constant (37.0 ± 13.4 ms vs. 39.3 ± 6.9 ms vs. 31.6 ± 11.0 ms, respectively; 
p = 0.90) did not differ. Finally, the amplitude (79.1 ± 7.2 pA vs. 52.3 ± 5.3 pA vs. 50.6 ± 
21.7 pA, for carrageenan-injected, sham and control; n = 3, 3, & 7 respectively, p = 0.66) and 
mean activation time constant (112.4 ± 17.5 ms vs. 108.7 ± 55.8 ms vs. 149.7 ± 31.0 ms, 
respectively; p = 0.68) of Ih were similar under each condition. 
In contrast, several properties of IAr were altered in the carrageenan-injected animals. The 
amplitude (238 ± 33 vs. 593 ± 167 pA vs. 494 ± 96 for carrageenan-injected, sham and 
control, n = 19, 14, & 18 respectively, p = 0.045) and inactivation time constant (12.9 ± 1.5 
vs. 15.3 ± 1.4 ms vs.22.1 ± 3.6, respectively; p = 0.031) were both reduced. Together, these 
results suggest the effect of IAr, the dominant subthreshold current in upper cervical SDH 
neurons (Figure 5B), is reduced in following acute neck muscle inflammation. 
Discussion 
We assessed the impact of two hours of acute neck muscle inflammation on the properties of 
SDH neurons in the upper cervical spinal cord. Our c-Fos experiments showed carrageenan-
induced muscle inflammation produced neuronal activation in both ipsilateral and 
contralateral laminae I – II, and to a lesser extent in lamina V of the C1 and C2 spinal 
segments. These findings confirmed that neurons in laminae I - II should be the principal 
target in subsequent electrophysiological recordings from acutely prepared spinal cord slices. 
Assessment of c-Fos expression, the protein product of the proto-oncogene c-fos, is a well-
established method for determining neuronal activation after noxious peripheral stimulation 
[19,20]. In our study, c-Fos expression occurred in neurons located predominantly in laminae 
I - II. This matches the terminal field distribution of nociceptive afferent fibres [2], and the 
location of c-Fos expressing neurons after application of noxious peripheral stimuli [20]. 
Some c-Fos labeling was also observed in deeper layers (lateral lamina V) of the dorsal horn. 
These superficial and deep locations closely match those noted in other rodent injury models 
involving deep tissues, such as muscle. For example in rat, chronic constriction injury of the 
sciatic nerve [21], adjuvant-induced arthritis [22], and nerve growth factor injection into 
semispinal neck muscles [23] resulted in c-Fos labelling in laminae I-II and V-VII. In 
contrast, capsaicin injection into the trapezius and splenius muscles of cats does not label 
many neurons in lamina II [24]. Thus, some differences exist in the extent to which neurons 
in laminae II are involved in processing noxious input from muscle across species. 
No labelling was observed in control or sham (saline injection) animals in our c-Fos 
experiments. These data suggest neither handling nor the manipulation of muscle tissue 
associated with the injection protocol resulted in significant activation of dorsal horn 
interneurons. Similar results have been observed for limb muscles when c-Fos expression has 
been compared with that in vehicle-injected animals [25]. Our unilateral carrageenan 
injections resulted in c-Fos labelling in both ipsilateral and contralateral superficial laminae 
(I-II) with some labelling in deeper laminae. Bilateral c-Fos expression has been observed 
after capsaicin injection into other neck muscles (trapezius and splenius capitis) in cats [24]. 
This contrasts with the data for limb muscles where inflammation produces neuronal 
activation that is confined to the ipsilateral side of the spinal cord. Thus, the major pattern of 
c-Fos activation we described following carrageenan injection into RCM, fits with activation 
of muscle nociceptive pathways in axial musculature. Thus, recording from neurons in 
ipsilateral laminae I-II should detect inflammation-related changes in the spinal dorsal horn. 
In our electrophysiological analysis of SDH neurons in spinal cord slices prepared two hours 
after RCM inflammation we observed two major changes: i) AMPA-mediated excitatory 
drive decreased and ii) the amplitude and kinetics of the rapid, but not slow IA type potassium 
current were altered. Assuming acute neck muscle inflammation enhanced nociceptive 
signaling (cf. our c-Fos results above), it is surprising that we found excitatory drive to SDH 
neurons was reduced (as assessed by sEPSC amplitude and charge). It is noteworthy, 
however, that other studies have also described reduced excitatory drive to SDH neurons in 
pain models, specifically in GAD67 positive inhibitory interneurons [26]. In these 
experiments the frequency of spontaneous excitatory input, rather than amplitude, was 
reduced in neuropathic animals. The authors proposed that reduced excitatory drive to 
inhibitory interneurons, when placed in the context of nociceptive signaling, would reduce 
inhibitory drive in the SDH and contribute to hyperalgesia. While our data does not allow us 
to identify recorded neurons as excitatory or inhibitory, similar plasticity in the form of 
reduced sEPSCs onto inhibitory interneurons would contribute to enhanced nociceptive 
signaling in acute neck muscle inflammation. 
Regardless of the identity of neurons that undergo reduced excitatory drive in our model, 
numerous studies have confirmed that inflammation alters the expression of AMPA type 
glutamate receptors. For example, expression of calcium permeable AMPA receptors 
containing GluR1 subunits has been shown to increase, whereas expression of calcium 
impermeable GluR2 containing subunits was reduced [27-31]. Importantly, all these studies 
assessed receptor expression 24 hours after peripheral inflammation. In contrast, our data 
showing sEPSC kinetics were unaltered in carrageenan-injected recordings imply that AMPA 
receptor expression is unchanged at the two-hour time point used following axial muscle 
inflammation. Phosphorylation of GluR1 and GluR2 has, however, been demonstrated at time 
points commensurate with those in our study [32]. This would enhance excitatory drive in 
SDH neurons. Importantly, most GluR1/2 subunit expression and phosphorylation studies 
have used biomolecular techniques in spinal cord homogenates where synaptic and 
extrasynaptic receptors and the precise laminae location of neurons are not known. Thus our 
experiments, which assessed synaptic receptor function in specific laminae, suggest levels of 
GluR plasticity vary according to time after inflammatory insult. 
Several electrophysiological studies have examined the properties of primary afferent 
synapses in the SDH after peripheral inflammation, and report that primary afferent synaptic 
function was generally enhanced [33,34]. Again this contrasts with the reduced excitatory 
drive that we observed. However, our sEPSCs recordings will have included excitatory 
currents arising from local interneurons, descending systems, as well as primary afferents. 
Relevant to this point, previous work has shown that ablation of afferent input by dorsal 
rhizotomy, or selective removal of peptidergic afferents with neonatal capsacin treatment, 
does not reduce mEPSC frequency recorded from SDH neurons in spinal slices [35,36]. This 
suggests that the majority of sEPSCs recorded in an isolated spinal slice such as that in our 
experiments, come from local interneurons and not primary afferent terminals. Thus, any 
change to primary afferent synapses may have gone undetected in our experiments. 
When sEPSCs have been recorded in the SDH in peripheral inflammation models it appears 
their properties are not altered within the first 24 hours after inflammation [37,38]. 
Interestingly, the Li et al. study showed that sEPSC frequency was enhanced when 
inflammatory insults were delivered to neonates but not in animals older than P14. The most 
likely explanation for the reduced sEPSC amplitudes we observed comes from work that has 
assessed the contribution of the initial primary afferent barrage and its time course during an 
inflammatory insult. For example, peripheral nerve block with lignocaine during muscle 
inflammation prevents the development of plasticity (or central sensitisation) in spinal 
neurons, whereas nerve block outside the first two hours of inflammation does not protect 
against central sensitisation [39]. This finding suggests primary afferent input within the first 
two hours of inflammation plays a crucial role in establishing central sensitisation. In our 
experiments, the barrage of primary afferent input would be expected to be the principle 
driver of central sensitisation, which is reflected as the expression of c-Fos in certain 
neuronal populations. The fact, however, that we did not observe an enhancement of sEPSC 
frequency or amplitude may partly be explained by the in vitro slice preparation we used. 
Specifically, previous work has shown that the removal of populations of primary afferent 
inputs either by dorsal rhizotomy or neonatal capsacin does not affect the properties of 
sEPSCs recorded in slices [35,38]. This implies that most sEPSCs recorded in slices originate 
from local interneurons rather than primary afferents. Further support of our interpretation 
comes from work in an in vitro hemisected spinal cord preparation where inflammation-
induced central sensitisation was only detected six hours after inflammation in the absence of 
peripheral input [34]. These data, when combined with our finding that excitatory drive is 
decreased two hours after acute muscle inflammation, suggests a complex sequence of events 
occurs over the onset, establishment and maintenance of inflammatory pain and associated 
central sensitisation. 
The reduced excitatory drive we observed two hours after acute neck muscle activation was 
accompanied by a reduction in the amplitude and time course of the IAr - type potassium 
current. IAr currents are expressed widely in the CNS and regulate AP discharge and neuronal 
output. In the dorsal horn, IAr currents are thought to play an important role in reducing 
neuronal excitability. For example, IAr currents are preferentially associated with the delayed 
firing pattern of AP discharge (Figure 4A). Likewise, SDH neurons expressing delayed firing 
and IAr currents exhibit reduced AP discharge compared to tonic firing and initial bursting 
neurons when activated by current protocols they are likely to receive in vivo (synaptic vs. 
square step current injection) [40]. Furthermore, a number of studies have suggested IAr 
expression is a feature of excitatory interneurons [41,42]. This suggests that diminished IAr 
would substantially increase excitability and nociceptive signaling in the dorsal horn. Thus, 
any intervention that reduces IAr current in SDH neurons leads to enhanced excitability. 
Comparable modulation of IAr in the dorsal horn has been reported after peripheral 
inflammation. For example, enhanced excitability in dorsal horn neurons is observed as early 
as one hour after carrageenan injection into the hindpaw of young (P7-12) mice [43]. A 
detailed analysis of IAr potassium currents in these animals identified a shift in the current’s 
steady state inactivation. The authors suggested this would act like “a relaxation of the brake 
on excitability at physiologically meaningful potentials”. Interestingly, we have previously 
demonstrated the converse (ie, enhanced braking) in spastic mice with glycine receptor 
mutations [18]. In this case, modulation of IAr was seen as a compensatory mechanism to 
enhance neuronal inhibition and maintain stable sensory processing. Together, this work 
suggests IAr can be strongly modulated to maintain an excitability set-point in the SDH. 
Importantly, a signalling pathway involving metabotropic glutamate receptor activation and 
extracellular signal-regulated kinase dependent phosphorylation of Kv4.2 channels has been 
shown to regulate IAr currents in SDH neurons [44,45]. Furthermore, this work demonstrated 
that inflammation of peripheral tissues can activate this pathway and reduce IAr. This 
provides a potential mechanism for our observations during acute neck muscle inflammation. 
Given IAr currents are diminished in SDH neurons from carrageenan-injected animals one 
might expect this to impact on neurons with the delayed- and reluctant firing AP discharge 
pattern as the two have been associated in a number of previous studies [18,46,47]. For 
example, diminished IAr would either reduce the delay before AP discharge or reduce the 
proportion of neurons exhibiting delayed and reluctant firing and convert them to more 
excitable forms of discharge such as tonic firing or initial bursting. There was, however, no 
difference in the incidence of AP discharge patterns across the three conditions: control, sham 
and carrageenan-injected. This finding may be explained, at least partly, by the biophysical 
properties of IAr currents, which are inactivated at depolarised membrane potentials [16,47]. 
The membrane potential of neurons in our recordings was approximately −60 mV across all 
three conditions. At this potential much of IAr (~80 - 90%) is inactivated and therefore not 
able to reduce or delay AP discharge. Under in vivo conditions, however, when membrane 
potential is fluctuating due to the combination of inhibitory and excitatory synaptic input, IAr 
currents could have a greater impact on neuronal output. Thus, under in vivo conditions the 
reduction in IAr we observed could enhance excitation and disrupt normal sensory processing. 
Ultimately, our findings must be placed in the context of the whole animal. Fortunately, 
relevant data are available on the time course of pain related behaviours following 
carrageenan injections. Most of this work has involved carrageenan injection into the plantar 
surface of the hindpaw [48-52] (rather than muscle). Carrageenan causes rapid edema, which 
peaks 3–4 hours post injection and largely resolves by 24–72 hours [53]. Behaviourally, 
carrageenan’s capacity to induce thermal and mechanical hyperalgesia is highly reproducible. 
These indices of altered pain sensation have been detected as early as 15 minutes after 
carrageenan injection [48], though typically studies report effects to be fully developed at 1–4 
hours [52]. Following onset, some variability exists in duration of the carrageenan-induced 
mechanical and thermal hyperalgeisa. This variability might reflect the carrageenan 
concentration (typically 1-3% is injected) as well as the species studied. However all work 
suggests mechanical and thermal hyperalgeisa persists for at least 24 hours [49]. The few 
studies that have injected carrageenan into muscle also support a rapid onset for mechanical 
and thermal hyperalgesia, which is fully developed by 2 hours and can last as long as 4–8 
weeks [54,55]. Thus our study has described a number of central changes to both the synaptic 
and intrinsic membrane properties of SDH neurons that equate to a relatively early time point 
in the carrageenan-induced inflammatory pain model. 
In summary, the present study suggests two hours of acute neck muscle inflammation 
represents a transition point between the involvements of peripheral and/or central 
sensitisation. As our study was undertaken at one time point post inflammation it is difficult 
to predict where each of the alterations we observed lies in terms of the train of events that 
leads to central sensitization. The surprising result that sEPSC amplitude and charge are 
reduced, suggest some excitatory inputs are depressed in the hours following inflammation. 
This may reduce local excitatory drive in the face of the initial excitatory barrage arising 
from the periphery. Alternatively, if the neurons that experience a reduction in excitatory 
drive were inhibitory, an associated reduction in the activity of this population would reduce 
inhibition in the SDH and contribute to enhanced nociceptive signaling. It will be important 
in future studies to assess whether our observation persists after peripheral drive abates 
following the resolution of inflammation in the periphery. The diminished IAr-current after 
two hours of acute inflammation is, however, consistent with inflammation-induced 
hyperexcitability in the spinal cord dorsal horn. Furthermore, there is a clear signalling 
pathway that links hyperexcitation (and neuronal depolarisation), with ERK kinase-dependent 
down regulation of A-currents [56]. Thus, the early barrage of afferent input from inflamed 
muscle could underpin this observation. Our findings when combined with the existing 
literature on altered spinal cord processing, albeit at longer times after acute insult, suggest a 
complex sequence of events occurs in the dorsal horn following neck muscle inflammation. A 
greater understanding of the order and duration of these changes may help to uncover new 
strategies for blocking the transition from peripheral to central sensitisation. 
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